Moderna
MRNA
MRNA
106 hedge funds and large institutions have $2.8B invested in Moderna in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
+27
Holders Change %
+34.18%
% of All Funds
2.3%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
45
Increased
25
Reduced
23
Closed
18
Calls
$6.91M
Puts
$5.9M
Net Calls
+$1.01M
Net Calls Change
+$995K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$25.6M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$17.3M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$15M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
| 5 |
BlackRock
New York
|
+$11M |
Top Sellers
| 1 |
HCM
Highline Capital Management
New York
|
-$12M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$8.41M |
| 3 |
AG
Artal Group
Luxembourg
|
-$5.09M |
| 4 |
SC
Samlyn Capital
New York
|
-$4.96M |
| 5 |
Neuberger Berman Group
New York
|
-$4.93M |
